Falls Church, February 10, 2015 —The American Thyroid Association (ATA) has championed the effort to include a daily serving of iodine in multivitamin/mineral supplements intended for pregnant and breastfeeding women, and it applauds the new guidelines released by the U.S. Council for Responsible Nutrition (CRN) advising manufacturers to include 150 micrograms of iodine to these daily supplements. This recommendation is based on scientific evidence that iodine is critical in early pregnancy to support fetal brain development. Pregnant and lactating women who do not get sufficient iodine in their diet may put their children at risk for decreased cognitive function.
The ATA had taken a leadership role in petitioning for a change in the Dietary Guidelines for Americans, according to Alex Stagnaro-Green, M.D., Dean, University of Illinois College of Medicine, Rockford. It coordinated the development of a joint proposal urging that iodine be included in all prenatal vitamin and mineral supplements, which was supported by five leading organizations: the Endocrine Society, American Association of Clinical Endocrinologists, Iodine Global Network (formerly the International Council for the Control of Iodine Deficiency Disorders), the Teratology Society, and the ATA.
“Pregnant and breastfeeding women in the United States are at risk for mild iodine deficiency,” says Dr. Stagnaro-Green. “The addition of 150 mcg of iodine in all prenatal vitamins will ensure that the developing brain of the baby during pregnancy and early infancy will have sufficient iodine to develop to its maximal potential.”
###
The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis, and treatment of thyroid disorders and thyroid cancer. ATA is an international membership medical society with over 1,700 members from 43 countries around the world. Celebrating its 92nd anniversary, the ATA delivers its mission — of being devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health — through several key endeavors: the publication of highly regarded professional journals, Thyroid, Clinical Thyroidology, and VideoEndocrinology; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease and thyroid cancer. The ATA promotes thyroid awareness and information through its online Clinical Thyroidology for the Public (distributed free of charge to over 11,000 patients and public subscribers) and extensive, authoritative explanations of thyroid disease and thyroid cancer in both English and Spanish. The ATA website provides reliable information on the Internet www.thyroid.org and serves as a bonafide clinical resource for patients and the public.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.